Sign Up Today and Learn More About EPINEX DIAGNOSTICS Stock

Invest in or calculate the value of your shares in EPINEX DIAGNOSTICS or other pre-IPO companies through EquityZen's platform.

Get Started


Epinex Diagnostics is a medical diagnostics company developing products for the identification of diabetes.





Tustin, CA, US

Total Funding


Epinex Diagnostics specializes in the application of its unique expertise in medical diagnostics to target major deficiencies in the existing healthcare market by developing innovative rapid tests that address those unexploited markets. The Epinex business model is based on development of products that address key deficiencies in the existing market structure while staying within the boundaries of ‘established’ health care practices and manufacturing technology. This combination limits risk and maximizes earnings potential. Our expertise lies in identifying key areas within the healthcare field where a lack of easily-accessible diagnostic information exists. Epinex Diagnostics was founded in 2002 by three pioneers in the biomedical device industry with a combined experience of more than 70 years in biomedical engineering, product design and development, and medical device marketing. They have been joined by an advisory board of distinguished scientists, experts in marketing and management, and leaders in the field of diabetic care. Epinex Diagnostics, Inc. is located in Tustin, California, adjacent to the University of California, Irvine, in the heart of the Southern California biomedical industry.


Leadership team at EPINEX DIAGNOSTICS

Vice President, Corporate Finance

Jeff Byrd

Chief Technology Officer

Henry J. Smith

Locked Features

Join now and verify your accreditation status to gain access to:

  • EPINEX DIAGNOSTICS current valuation
  • EPINEX DIAGNOSTICS stock price
  • Available deals in EPINEX DIAGNOSTICS and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

How to invest in EPINEX DIAGNOSTICS stock?

Accredited investors can buy pre-IPO stock in companies like EPINEX DIAGNOSTICS through EquityZen funds. These investments are made available by existing EPINEX DIAGNOSTICS shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell EPINEX DIAGNOSTICS stock?

Shareholders can sell their EPINEX DIAGNOSTICS stock through EquityZen's private company marketplace. EquityZen's network includes over 310K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 41K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."